UniQure presses go on Huntington’s gene therapy trial

Sanofi hands back neurology gene therapy rights to Voyager

Sanofi’s Genzyme unit has handed back rights to two neurology gene therapies to US biotech Voyager Therapeutics, as part of a rethink of the companies’ joint research.

New Huntington’s drug granted priority designation

Roche’s treatment for Huntington’s disease has received a priority designation by the European regulator, sparking hope that a cure may be in the pipeline.

Roche takes on development of potential Huntington’s breakth...

Ionis has completed its licensing agreement with Roche for IONIS-HTTRx, a drug which could be a breakthrough in treating Huntington’s disease.

Huntington's Disease wearable gets backing from NIH

BioSensics' HDWear provides real-time motor function scores in Huntington's patients.

FDA approves Teva's Huntington's Disease drug

First treatment approved for Huntington's Disease in almost a decade.